Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and Erythropoetin in Decompensated Liver Disease
NCT01384565Phase 3Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2011
- Primary completion
- Nov 2012
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of filgrastim, darbepoetin alfa in Liver cirrhosis (LC), sponsored by Institute of Liver and Biliary Sciences. Started Jul 2011; status: completed.
02
Drugs
filgrastimdarbepoetin alfa
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01384565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384565.